[PHARMA] QoQ Quarter Result on 30-Sep-2016 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
21-Nov-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
30-Sep-2016 [#3]
Profit Trend
QoQ- -12.9%
YoY- -34.6%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 517,967 618,294 582,816 515,215 531,796 559,195 680,150 -16.62%
PBT 10,150 27,777 4,069 19,923 21,487 26,538 23,717 -43.23%
Tax -399 -8,519 -4,969 -7,275 -5,846 -8,068 -7,676 -86.09%
NP 9,751 19,258 -900 12,648 15,641 18,470 16,041 -28.26%
-
NP to SH 9,520 18,923 -836 13,061 14,995 18,379 16,062 -29.46%
-
Tax Rate 3.93% 30.67% 122.12% 36.52% 27.21% 30.40% 32.36% -
Total Cost 508,216 599,036 583,716 502,567 516,155 540,725 664,109 -16.34%
-
Net Worth 542,147 544,360 531,169 531,250 524,177 515,906 529,786 1.55%
Dividend
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Div 10,376 10,368 7,773 10,365 12,949 10,354 18,134 -31.10%
Div Payout % 108.99% 54.79% 0.00% 79.37% 86.36% 56.34% 112.90% -
Equity
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Net Worth 542,147 544,360 531,169 531,250 524,177 515,906 529,786 1.55%
NOSH 259,400 259,219 259,377 259,146 258,981 258,859 259,064 0.08%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin 1.88% 3.11% -0.15% 2.45% 2.94% 3.30% 2.36% -
ROE 1.76% 3.48% -0.16% 2.46% 2.86% 3.56% 3.03% -
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
RPS 199.68 238.52 224.93 198.81 205.34 216.02 262.54 -16.69%
EPS 3.67 7.30 -0.32 5.04 5.79 7.10 6.20 -29.52%
DPS 4.00 4.00 3.00 4.00 5.00 4.00 7.00 -31.16%
NAPS 2.09 2.10 2.05 2.05 2.024 1.993 2.045 1.46%
Adjusted Per Share Value based on latest NOSH - 259,146
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
RPS 35.94 42.90 40.44 35.75 36.90 38.80 47.19 -16.61%
EPS 0.66 1.31 -0.06 0.91 1.04 1.28 1.11 -29.31%
DPS 0.72 0.72 0.54 0.72 0.90 0.72 1.26 -31.16%
NAPS 0.3762 0.3777 0.3686 0.3686 0.3637 0.358 0.3676 1.55%
Price Multiplier on Financial Quarter End Date
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Date 30/06/17 31/03/17 30/12/16 30/09/16 30/06/16 31/03/16 31/12/15 -
Price 4.58 4.89 5.30 5.58 5.50 5.76 6.36 -
P/RPS 2.29 2.05 2.36 2.81 2.68 2.67 2.42 -3.61%
P/EPS 124.80 66.99 -1,642.66 110.71 94.99 81.13 102.58 13.97%
EY 0.80 1.49 -0.06 0.90 1.05 1.23 0.97 -12.06%
DY 0.87 0.82 0.57 0.72 0.91 0.69 1.10 -14.48%
P/NAPS 2.19 2.33 2.59 2.72 2.72 2.89 3.11 -20.86%
Price Multiplier on Announcement Date
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Date 16/08/17 16/05/17 21/02/17 21/11/16 19/08/16 13/05/16 15/02/16 -
Price 4.19 4.72 5.12 5.70 5.62 5.60 6.19 -
P/RPS 2.10 1.98 2.28 2.87 2.74 2.59 2.36 -7.49%
P/EPS 114.17 64.66 -1,586.88 113.10 97.06 78.87 99.84 9.36%
EY 0.88 1.55 -0.06 0.88 1.03 1.27 1.00 -8.17%
DY 0.95 0.85 0.59 0.70 0.89 0.71 1.13 -10.93%
P/NAPS 2.00 2.25 2.50 2.78 2.78 2.81 3.03 -24.20%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment